Literature DB >> 26297915

Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1.

Bidisha Paul Chowdhury1, Shibali Das1, Saikat Majumder1, Kuntal Halder1, Sweta Ghosh1, Satabdi Biswas1, Syamdas Bandyopadhyay1, Subrata Majumdar2.   

Abstract

Visceral leishmaniasis (VL), caused by a protozoan parasite Leishmania donovani, is still a threat to mankind due to treatment failure, drug resistance and coinfection with HIV. The limitations of first-line drugs have led to the development of new strategies to combat this dreaded disease. Recently, we have shown the immunomodulatory property of Ara-LAM, a TLR2 ligand, against leishmanial pathogenesis. In this study, we have extended our study to the effect of Ara-LAM on regulatory T cells in a murine model of VL. We observed that Ara-LAM-treated infected BALB/c mice showed a strong host-protective Th1 immune response due to reduced IL-10 and TGF-β production, along with marked decrease in CD4(+) CD25(+) Foxp3(+) GITR(+) CTLA4(+) regulatory T cell (Treg) generation and activation. The reduction in Foxp3 expression was due to effective modulation of TGF-β-induced SMAD signaling in Treg cells by Ara-LAM. Moreover, we demonstrated that Ara-LAM-induced IRF1 expression in the Treg cells, which negatively regulated foxp3 gene transcription, resulting in the reduced immunosuppressive activity of Treg cells. Interestingly, irf1 gene knockdown completely abrogated the effect of Ara-LAM on Treg cells. Thus, these findings provide detailed mechanistic insight into Ara-LAM-mediated modulation of Treg cells, which might be helpful in combating VL. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Ara-LAM; Foxp3; IRF1; Leishmania donovani; TGF-β; regulatory T cell

Mesh:

Substances:

Year:  2015        PMID: 26297915      PMCID: PMC4626582          DOI: 10.1093/femspd/ftv063

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  37 in total

1.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

2.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

3.  Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.

Authors:  Gilles Boschetti; Stéphane Nancey; Fatima Sardi; Xavier Roblin; Bernard Flourié; Dominique Kaiserlian
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

4.  Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function.

Authors:  G Lal; N Yin; J Xu; M Lin; S Schroppel; Y Ding; I Marie; D E Levy; J S Bromberg
Journal:  Am J Transplant       Date:  2011-01-10       Impact factor: 8.086

Review 5.  Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?

Authors:  Manu Vanaerschot; Franck Dumetz; Syamal Roy; Alicia Ponte-Sucre; Jorge Arevalo; Jean-Claude Dujardin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-05-06       Impact factor: 5.091

6.  TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.

Authors:  Song Guo Zheng; Ju Hua Wang; William Stohl; Kyoung Soo Kim; J Dixon Gray; David A Horwitz
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

7.  Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.

Authors:  Miroslaw J Szczepanski; Marta Szajnik; Malgorzata Czystowska; Magis Mandapathil; Laura Strauss; Ann Welsh; Kenneth A Foon; Theresa L Whiteside; Michael Boyiadzis
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

Review 8.  The interferon regulatory factor family in host defense: mechanism of action.

Authors:  Keiko Ozato; Prafullakumar Tailor; Toru Kubota
Journal:  J Biol Chem       Date:  2007-05-14       Impact factor: 5.157

9.  Toll-like receptors in leishmania infections: guardians or promoters?

Authors:  Marilia S Faria; Flavia C G Reis; Ana Paula C A Lima
Journal:  J Parasitol Res       Date:  2012-03-15

10.  The host-protective effect of arabinosylated lipoarabinomannan against Leishmania donovani infection is associated with restoration of IFN-γ responsiveness.

Authors:  Bidisha Paul Chowdhury; Syamdas Bandyopadhyay; Shibali Das; Saikat Majumder; Mukesh Kumar Jha; Suchandra Bhattacharyya Majumdar; Bhaskar Saha; Subrata Majumdar
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

View more
  4 in total

1.  B-1 cells modulate the murine macrophage response to Leishmania major infection.

Authors:  Angelica F Arcanjo; Marise P Nunes; Elias B Silva-Junior; Monique Leandro; Juliana Dutra Barbosa da Rocha; Alexandre Morrot; Debora Decote-Ricardo; Celio Geraldo Freire-de-Lima
Journal:  World J Biol Chem       Date:  2017-05-26

2.  EB1-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity.

Authors:  Mohammad Asad; Abdus Sabur; Mohammad Shadab; Sonali Das; Mohd Kamran; Nicky Didwania; Nahid Ali
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

3.  Seminal Plasma Modifies the Transcriptional Pattern of the Endometrium and Advances Embryo Development in Pigs.

Authors:  Cristina A Martinez; Josep M Cambra; Inmaculada Parrilla; Jordi Roca; Graça Ferreira-Dias; Francisco J Pallares; Xiomara Lucas; Juan M Vazquez; Emilio A Martinez; Maria A Gil; Heriberto Rodriguez-Martinez; Cristina Cuello; Manuel Álvarez-Rodriguez
Journal:  Front Vet Sci       Date:  2019-12-18

4.  Toll-Like Receptor 2 Is Required for Inflammatory Process Development during Leishmania infantum Infection.

Authors:  Laís A Sacramento; Jéssica L da Costa; Mikhael H F de Lima; Pedro A Sampaio; Roque P Almeida; Fernando Q Cunha; João S Silva; Vanessa Carregaro
Journal:  Front Microbiol       Date:  2017-02-23       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.